Vojta Therapy Versus Conservative Therapy for Patients With Stroke

NCT07307001 | Not Yet Recruiting

• 1 other identifier: 85/22.05.2025
• Study Type: interventional
• Target: 150
• Locations: 1 country
• Sites: 1

Brief Summary

Main hypothesis: Vojta Therapy shows significantly better results in regaining functional independence for patients with ischemic stroke than the Conservative Therapy The present study wishes to bring evidence that Vojta Therapy is superior in regaining functional independence for patients with ischemic stroke, whether it is solely used in the intervention, or as a complementary tool along with the Conservative Therapy.

Conditions

Stroke, Ischemic

Outcome Measures

Primary Outcomes (2)

• Trunk Control Test (TCT)

  The Trunk Control Test (TCT) will be used to assess the motor function and control of the trunk in participants. The scale contains 5 task-items, each of them being scored between 0 (unable, needs help), 12 (able but abnormal), or 25 (able, normal). The scoring interval is 0-100, where 100 signify better trunk function, and 0 none.

  From enrollment to the end of treatment at 2 weeks, and a follow up at 3 months

• Functional Independence Measure (FIM)

  The Functional Independence Measure (FIM) will be used to assess the level of a participant's functional independence in activities of daily living. The test comprises in 18 items, each of which is assigned against a seven-point ordinal scale, where the higher the score for an item, the more independently the patient is able to perform the tasks assessed by that item. Total scores range from 18 to 126.

  From enrollment to the end of treatment at 2 weeks, and a follow-up at 3 months

Secondary Outcomes (8)

• Trunk Impairment Scale (TIS)

  From enrollment to the end of the treatment at 2 weeks, and a follow-up at 3 months

• Postural Assessment Scale for Stroke (PASS)

  From enrollment to the end of the treatment at 2 weeks, and a follow-up at 3 months.

• Berg Balance Scale (BBS)

  From enrollment to the end of the treatment at 2 weeks, and a follow-up at 3 months.

• Barthel Index

  From enrollment to the end of the treatment at 2 weeks, and a follow-up at 3 months.

• Nottingham Extended ADL

  From enrollment to the end of the treatment at 2 weeks, and a follow-up at 3 months.

Other Outcomes (3)

• Stroke Impact Scale (SIS)

  From enrollment to the end of the treatment at 2 weeks, and a follow-up at 3 months.

• EuroQol-5 Dimension (EQ-5D)

  From enrollment to the end of the treatment at 2 weeks, and a follow-up at 3 months.

• Stroke Specific Quality of Life (SS-QoL)

  From enrollment to the end of the treatment at 2 weeks, and a follow-up at 3 months.

Study Arms (2)

Control group

ACTIVE COMPARATOR

The physiotherapists will apply only the Conservative Therapy to the subjects in this group

Procedure: Conservative therapy

Study Group

EXPERIMENTAL

The physiotherapists will apply the Conservative Therapy, and in addition will also apply the Vojta Therapy

Procedure: Vojta therapy; Procedure: Conservative therapy

Interventions

Vojta therapy PROCEDURE

The physiotherapists will apply the techniques and methods of Vojta therapy along with the classical tools of the Conservative therapy. Through the therapeutic use of reflex locomotion involved in Vojta sessions, it can succeed in elementary movement models, meaning that they can be accessible again for patients with central nervous system and musculoskeletal affections.

Study Group

Conservative therapy PROCEDURE

The physiotherapists will apply only the classical tools and methods involved in the Conservative therapy (Bobath, massage, electrotherapy, hydrotherapy).

Control group; Study Group

Eligibility Criteria

• Age: 45 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• patients post-ischemic stroke
• patients who meet the age criteria
• patients who have had the stroke in less than 3 years ago

You may not qualify if:

• patients with hemoragic stroke
• patients with comorbidities
• noncooperative patients

Sponsors & Collaborators

• Lucaci Doru Nicolae: lead

Study Sites (1)

Auxologico President Recovery Hospital

Cordău, 417499, Romania

Location

MeSH Terms

Conditions

Ischemic Stroke

Interventions

Conservative Treatment

Condition Hierarchy (Ancestors)

Stroke; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

• Doru Nicolae Lucaci, PhD

  Auxologico President

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Doru Nicolae Lucaci, PhD

CONTACT

+40744664991; lucaci_doru2001@yahoo.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Physiotherapist

Study Record Dates

• First Submitted: December 13, 2025
• First Posted: December 29, 2025
• Study Start: February 2, 2026
• Primary Completion (Estimated): May 29, 2026
• Study Completion (Estimated): July 30, 2026
• Last Updated: January 7, 2026

Record last verified: 2025-12

Data Sharing

• IPD Sharing: Will not share

Locations

RO (1)